For a list of contributors to this study, see the ‡ on page 413.
Expedited Publication
A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease†
Article first published online: 28 AUG 2003
DOI: 10.1002/ana.10720
Copyright © 2003 American Neurological Association
Additional Information
How to Cite
Olanow, C. W., Goetz, C. G., Kordower, J. H., Stoessl, A. J., Sossi, V., Brin, M. F., Shannon, K. M., Nauert, G. M., Perl, D. P., Godbold, J. and Freeman, T. B. (2003), A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol., 54: 403–414. doi: 10.1002/ana.10720
- †
Publication History
- Issue published online: 28 AUG 2003
- Article first published online: 28 AUG 2003
- Manuscript Revised: 15 JUL 2003
- Manuscript Accepted: 15 JUL 2003
- Manuscript Received: 19 JUN 2003
Funded by
- National Institutes of Health. Grant Number: NS32842
- Bendheim Parkinson's Disease Center
- Bachman Strauss Dystonia and Parkinson Foundation
- Abstract
- Article
- References
- Cited By
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via Athens http://onlinelibrary.wiley.com/athens or other institutional login options http://onlinelibrary.wiley.com/login-options .
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!

1531-8249/asset/olbannerleft.gif?v=1&s=d36d5ebb3caa1b29d7f078a97c52973b0963daf2)
1531-8249/asset/olbannerright.gif?v=1&s=078041b213f6959d63575a593f880457c45116f0)
1531-8249/asset/cover.gif?v=1&s=685ec69724c5ed4c8847ce939e70ceb45065856f)